Abstract:IntroductionA rise in cytosolic free Ca2+ concentration ([Ca2+]cyt) in pulmonary arterial smooth muscle cells (PASMCs) causes pulmonary vasoconstriction and increases PASMC proliferation, leading to concentric arterial wall thickening. Ca2+/Calmodulin‐Dependent Protein Kinases (CaMK) are a family of serine/threonine kinases that are activated by an increase in [Ca2+]cyt. Akt is another serine/threonine protein kinase that has been observed to have increased activity due to a rise in [Ca2+]cyt, and its overexpression has been implicated in excessive cell proliferation. CaMKIV has been shown to cause phosphorylation of Akt while CaMKIIδ has been shown to cause increases in vascular remodeling and vascular smooth muscle cell proliferation. STIM2, a Ca2+ sensor in sarcoplasmic reticulum (SR), has been suggested to mediate increases in the resting [Ca2+]cyt in PASMCs from patients with idiopathic pulmonary arterial hypertension (IPAH). PDGF‐R is a tyrosine kinase receptor that, when activated by PDGF, can cause cell proliferation. Our hypothesis is that overactivation of CaMKIV and CaMKIIδ increases activity of Akt, causing upregulation of STIM2 and PDGF‐R, which stimulate PASMC proliferation in patients with IPAH.MethodsPASMCs from both healthy subjects and patients with IPAH were used for this study. Measurement of protein levels was done using conventional western blot protocol. Knockdown of specific proteins was done using siRNA. Measurement of cell proliferation was done by measuring EdU incorporation rate, an indicator of DNA synthesis, and total cell number after 48 hours.ResultsIn this study, we found that the protein level of CaMKIV is significantly increased in PASMCs from patients with IPAH (1.00±0.588 vs 11.4±1.29, n=3 normal subjects and 5 patients, p=0.001). Knockdown of CaMKIV in IPAH PASMCs with CaMK IV specific siRNA significantly decreased the protein level of STIM2, PDGF‐R‐α and PDGF‐R‐β, and also significantly decreased cell proliferation, which is indicated by the decreased EdU incorporation rate and total cell number in IPAH PASMCs. Knockdown of CaMKIIδ significantly decreased phosphorylation of Akt, EdU incorporation rate and total cell number. In addition, knockdown of Akt resulted in a decrease in STIM2 and PDGF‐R‐β.ConclusionTogether, these data indicate that overactivation of CaMKIV and CaMKIIδ in IPAH PASMCs, due to upregulation of CaMKIV, CaMKIIδ and/or increased resting [Ca2+]cyt, contributes to enhancing PASMCs proliferation by increasing activation of Akt, causing upregulation of STIM2 and PDGF‐R. CaMKIV and CaMKIIδ activation‐induced upregulation of STIM2 will further raise the resting [Ca2+]cyt and subsequently activate CaMKIV and CaMKIIδ, forming a positive feedback loop. The overactivation of CaMKIV and CaMKIIδ may be an important mechanism involved in sustained pulmonary vasoconstriction and excessive pulmonary vascular remodeling in patients with IPAH.Support or Funding InformationThis work was supported in part by the grants from the National Heart, Lung and Blood Institute of the National Institutes of Health (HL135807 and HL125208).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Ca2+/Calmodulin-Dependent Protein Kinase II Mediates Platelet-Derived Growth Factor-Induced Human Hepatic Stellate Cell Proliferation

Ca2+/calmodulin‐ Dependent Protein Kinase II Mediates Transforming Growth Factor‐β‐induced Hepatic Stellate Cells Proliferation but Not in Collagen Α1(i) Production

PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/-catenin signalling pathway

[Effect of Protein Kinase C/transforming Growth Factor Beta 1 Pathway on Activation of Hepatic Stellate Cells].

Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of LI90, a human hepatic stellate cell line

CaM/CaMKII mediates activation and proliferation of hepatic stellate cells regulated by ASIC1a

[Regulation of Hepatic Stellate Cell Activation by Interleukin-10/Platelet Derived Growth Factor/mitogen-Activated Protein Kinase Pathway].

Parathyroid Hormone Receptor-1 Signaling Aggravates Hepatic Fibrosis Through Upregulating Camp Response Element-Binding Protein-Like 2.

Expression of Platelet-Derived Growth Factor-Bb in Liver Tissues of Patients with Chronic Hepatitis B.

Overactivation of Ca2+/Calmodulin‐Dependent Protein Kinase IV and IIδ Contributes to Enhancing Pulmonary Arterial Smooth Muscle Cell Proliferation in Patients with Idiopathic Pulmonary Arterial Hypertension

The Antihepatic Fibrotic Effects of Fluorofenidone Via Mapk Signalling Pathways

PI3‐kinase/Akt pathway‐regulated membrane transportation of acid‐sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF‐induced HSC Activation

Extent of extracellular signal-regulated kinases phosphorylation determines the sensitivity of hepatic stellate cells to staurosporine-induced apoptosis.

PPAR Gamma Inhibits Growth of Rat Hepatic Stellate Cells and TGF Beta-Induced Connective Tissue Growth Factor Expression

Therapeutic Targeting of the PDGF and TGF-β-signaling Pathways in Hepatic Stellate Cells by PTK787/ZK22258

Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells

An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis

Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90

Role of Protein Kinase C in the Process of Hepatocyte Growth Factor inducing Vascular Endothelial Growth Factor in MHCC97H

Role of Rhoa in Platelet-Derived Growth Factor-Bb-Induced Migration of Rat Hepatic Stellate Cells